{"id":"W4282918298","doi":"10.1358/dot.2022.58.6.3400572","title":"Bimekizumab for psoriasis","year":2022,"lang":"en","type":"article","venue":"Drugs of today","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Secukinumab; Psoriasis; Ustekinumab; Tolerability; Adalimumab; Adverse effect; Dermatology; Immunology; Immune system; Population; Internal medicine; Tumor necrosis factor alpha; Psoriatic arthritis","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004047719,0.000438864,0.000426607,0.0004413268,0.0003494864,0.0005312691,0.0003094828,0.001048674,0.02028631],"category_scores_gemma":[0.0005105438,0.00007717156,0.0005009832,0.0002434442,0.0001729531,0.0004498784,0.0005087388,0.002100772,0.0111667],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003984194,"about_ca_system_score_gemma":0.000450217,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001795485,"about_ca_topic_score_gemma":0.0004504085,"domain_scores_codex":[0.9998192,0.00003093687,0.00001430282,0.00002817775,0.00006953923,0.00003786353],"domain_scores_gemma":[0.9998533,0.00002281642,0.00002400844,0.000008268234,0.00002784781,0.00006377675],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005331149,0.0002915748,0.0004118324,0.0008887532,0.00005135854,0.0008423161,0.00003920682,0.0001153143,0.004936821,0.003880175,0.1771059,0.8109037],"study_design_scores_gemma":[0.0005665844,0.0006114419,0.001092579,0.0004563065,0.0000417743,0.004912429,0.00001674744,0.0001684226,0.001513617,0.0027935,0.9878154,0.00001132153],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0155751,0.7783365,0.004332958,0.04261348,0.01648116,0.0003141126,0.0006732831,0.00095428,0.1407192],"genre_scores_gemma":[0.1643677,0.4517857,0.01024035,0.07384626,0.02709869,0.0004101796,0.002330655,0.0002470391,0.2696734],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02028631,"threshold_uncertainty_score":0.06786448,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01460619210585043,"score_gpt":0.24055590479578,"score_spread":0.2259497126899296,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}